can bpc 157 cause cancer The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and Safety What is BPC-157 and How

The compound is still working through Eli Lilly's TRIUMPH Phase 3 program, with seven additional trial readouts expected through 2026 alongside the already-reported TRIUMPH-4 data from December 2025

The table is scientific and comparative in nature and does not constitute a direct head-to-head comparison or a claim about the effect of the research-grade product

This distinction matters because FDA approval involves a formal review of safety, effectiveness, manufacturing quality, labeling, and intended use

By getting a shot you are bypassing the GI tract and allowing for 100% absorption into the body straight into the cells

4 weeks supply per box Made in a cGMP certified facility in the USA Questions or Concerns

The timing question: when to inject each compound Timing matters more for AOD 9604 than for tirzepatide, and getting this wrong can significantly reduce AOD 9604 effectiveness while having almost no impact on tirzepatide response